CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Operating Lease, Liability, Noncurrent in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Charles River Laboratories International, Inc. quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q4 2018 to Q3 2024.
  • Charles River Laboratories International, Inc. Operating Lease, Liability, Noncurrent for the quarter ending September 28, 2024 was $433M, a 10.9% increase year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $433M +$42.4M +10.9% Sep 28, 2024 10-Q 2024-11-06
Q2 2024 $429M +$27M +6.71% Jun 29, 2024 10-Q 2024-08-07
Q1 2024 $418M -$148K -0.04% Mar 30, 2024 10-Q 2024-05-09
Q4 2023 $419M +$29.5M +7.57% Dec 30, 2023 10-Q 2024-11-06
Q3 2023 $390M +$21.6M +5.85% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $402M +$35.9M +9.8% Jul 1, 2023 10-Q 2023-08-09
Q1 2023 $418M +$154M +58.2% Apr 1, 2023 10-Q 2023-05-11
Q4 2022 $390M +$137M +54.1% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $369M +$125M +51.2% Sep 24, 2022 10-Q 2022-11-02
Q2 2022 $366M +$126M +52.7% Jun 25, 2022 10-Q 2022-08-03
Q1 2022 $264M +$91.3M +52.8% Mar 26, 2022 10-Q 2022-05-04
Q4 2021 $253M +$97.4M +62.6% Dec 25, 2021 10-K 2023-02-22
Q3 2021 $244M +$97.4M +66.5% Sep 25, 2021 10-Q 2021-11-03
Q2 2021 $239M +$92.1M +62.5% Jun 26, 2021 10-Q 2021-08-04
Q1 2021 $173M +$39.6M +29.7% Mar 27, 2021 10-Q 2021-05-04
Q4 2020 $156M +$39.3M +33.8% Dec 26, 2020 10-K 2022-02-16
Q3 2020 $147M +$29.7M +25.4% Sep 26, 2020 10-Q 2020-11-09
Q2 2020 $147M +$39M +36% Jun 27, 2020 10-Q 2020-08-05
Q1 2020 $133M +$24.4M +22.4% Mar 28, 2020 10-Q 2020-05-07
Q4 2019 $116M +$4.68M +4.2% Dec 28, 2019 10-K 2021-02-17
Q3 2019 $117M Sep 28, 2019 10-Q 2019-11-06
Q2 2019 $108M Jun 29, 2019 10-Q 2019-07-31
Q1 2019 $109M Mar 30, 2019 10-Q 2019-05-07
Q4 2018 $112M Dec 30, 2018 10-K 2020-02-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.